Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings with branded versions of Lilly's tirzepatide — the active ingredient in weight-loss drug ...

Hims & Hers Health HIMS-10.35%decrease; red down pointing triangle said it is expanding its weight-loss offerings with the addition of Eli Lilly LLY-3.56%decrease; red down pointing triangle & Co ...

Slim Stainless Steel Memobottle: This bottle is uniquely shaped—long and slender, like a pencil case—to take up less room in your personal-item bag than a traditional water bottle. However ...

Hims & Hers Health announces that it's expanding access to personalized weight loss care. Hims & Hers will offer both Lilly's Zepbound and Mounjaro on its platform, as well as generic versions of ...

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up by as much as 14% earlier. That jump came as the S&P 500 and Nasdaq Composite showed ...

Hims & Hers Health shares closed up 5% on Tuesday after the company announced patients can access Eli Lilly's weight loss medication Zepbound and diabetes drug Mounjaro, as well as the generic ...

Hims & Hers offers both branded and cheaper versions of Novo's weight-loss drug Wegovy. (Image Credits: Pixabay) Telehealth firm Hims & Hers Health on Tuesday announced that it plans to sell Eli ...

While there's still plenty of work to be done, Hims is one of many such companies that's helping to expand healthcare options, by opening the conversation around men's health, in particular.